Position Vacant: Executive Officer, Hepatitis ACT

April 2018 Are you a dynamic leader with a track record in leading not-for-profit organisations? Do you have a passion for making a difference? Do you want to lead a committed team working to reduce hepatitis infection, increase treatment rates and reduce the impact of hepatitis for affected people? Hepatitis ACT is looking for a […]


Media Release: 9 March 2018 The inclusion of the recommendation to introduce a needle and syringe program (NSP) within Canberra’s prison in the ACT Health Service Commissioner’s review of the opioid replacement treatment program at the Alexander Maconochie Centre (AMC) released today has been welcomed by Hepatitis ACT. “This review continues to build the picture […]

Shine a Spotlight on Liver Disease for World Cancer Day

Media Release: 3 February 2018 Shine a Spotlight on Liver Disease for World Cancer Day On Sunday 4 February 2018 – World Cancer Day – Hepatitis ACT  joins with thousands of organisations globally and locally in highlighting the devastating impact cancer can have on individuals, families and communities across the world. Hepatitis ACT Executive Officer […]

A Timely Reminder: Hepatitis A is Vaccine-Preventable.

Following 27 confirmed hepatitis A cases in 9 months affecting men who have sex with men (MSM) (and to a lesser extent people who inject drugs) in Victoria, and a further 13 cases in South Australia since November 2017, senior public health officials in those states have issued advice promoting hepatitis A vaccinations. There have […]

Great progress on viral hepatitis but still too early to celebrate

HEPATITIS AUSTRALIA Media Release 6 November 2017 The number of Australians living with hepatitis C and advanced liver disease has fallen for the first time in ten years but elimination of the virus remains uncertain, according to campaigners. Published today, the Kirby Institute’s latest Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible Infections […]

2017 Hepatitis C Change Makers

Hepatitis ACT congratulates the 18 hepatitis C change makers recognised for their innovative, replicable, scalable, feasible and meaningful impacts in hepatitis C elimination. In particular we acknowledge the three Australian recipients: Helen Tyrrell (Hepatitis Australia), Melanie Eagle (Hepatitis Victoria) and Professor Greg Dore (UNSW; St Vincent’s Hospital). The Economist Intelligence Unit HCV C Change Makers […]